Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta‐analysis.
Abstract: Background and Aims: There are a limited number of pharmacotherapies licensed for alcohol use disorders (AUDs). Baclofen is a γ‐aminobutyric acid B (GABA‐B) agonist which is used increasingly as an off‐label treatment. A meta‐analysis of randomized controlled trials (RCTs) was conducted to...
| Publicado en: | Addiction Vol. 113; no. 8; pp. 1396 - 1407 |
|---|---|
| Autores principales: | , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Aug2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |